ANTHONY PICCOLO: Open Payments
NPI 1164933149 · VERONA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,091 in 47 payments from 13 companies in 2025. Trend: 2023 $265 · 2024 $989 · 2025 $1,091
Food & beverage: $1,021Education: $70
| Company | Payments | Amount |
|---|---|---|
| ARS Pharmaceuticals Operations, Inc. | 13 | $266 |
| AstraZeneca Pharmaceuticals LP | 6 | $244 |
| GENZYME CORPORATION | 8 | $168 |
| Regeneron Healthcare Solutions, Inc. | 6 | $109 |
| SANOFI-AVENTIS U.S. LLC | 1 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Genentech USA, Inc. | 2 | $34 |
| Optinose US, Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
Products named: DUPIXENT, NEFFY, TEZSPIRE, AIRSUPRA, NUCALA, XHANCE, Rhapsido, Xolair.
Industry payments across NJ — which companies pay providers there.
